UTHealth Houston / TIRR Memorial Hermann

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization	central nervous system disorder, injury, nervous system disorder, nervous system injury, spinal cord disorder, spinal cord injury	Recruiting	Phase 1 / Phase 2	2026-09-03		NCT06596291
Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urological Manifestations, central nervous system disorder, injury, nervous system disorder, nervous system injury, overactive bladder, spinal cord disorder, spinal cord injury, urinary bladder disorder, urinary system disorder	Not yet recruiting	Phase 1 / Phase 2	2025-11-12		NCT07227285

Clinical trials